Male Infertility . Virtual Preceptorship:
The Male partner in front stage to improve ART succes
3 May - 30 june 2021
scroll-down-icon

Overview

Andrology, the branch of medicine concerned with male sexual and reproductive health, emerged as a specialty at the end of the nineteenth century. However, it was not until the latter half of the past century that andrology had been recognized as one of the most intriguing sub-specialties of human reproduction. The demand for andrologists and reproductive urologists is increasing; however, there are insufficient experts to keep pace with the requirement.

The scope of modern andrology covers a broad spectrum from genetic studies to assisted reproduction techniques, and there is a clear need for updating healthcare professionals in these aspects.

This preceptorship will offer urologists, gynecologists, embryologists, andrologists and scientists working in ART an opportunity to learn the tools to implement reproductive andrology in a Fertility Center. The participants will be guided by international experts through lectures, debates and interactive discussions.
Apart from providing new insights into male infertility, this educational activity will give a guided journey through a modern centre specialise

Learning Objectives

  • With this preceptorship, the participants will learn how to standardize the male infertility evaluation and its importance for ART success. They will also learn about basic and specialized sperm function tests, how to order and interpret results. Participants will acquire knowledge on the most effective treatments for the infertile male and how they can add value to improve ART success. The course will also touch on quality management and how to set up a successful sperm retrieval program.

Target Audience

The program is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.

Male Infertility Virtual Preceptorship:

The Male partner in front stage to improve ART succes

3 may · 30 june 2021

Preliminary Programme

Download the PDF preliminary programme
Download

Language

The official language of the activity will be English. Translation in Chinese; Portuguese; Spanish for the video lectures will be provided.

Visual Maps

PDFs to download

Office Based Minimally Invasive MESA

Download

Microdissection Testicular Sperm Extraction

Download

Chairs

Sandro Esteves

Campinas, Brazil
Biography

R. Matthew Coward

Chapel Hill, NC, USA
Biography

Co-Chairs

Carlo Alviggi

Naples, Italy
Biography

Robert Fisher

Hamburg, Germany
Biography

Peter Humaidan

Aarhus, Denmark
Biography

Speakers

Androfert · Andrology and Human Reproduction Clinic Campinas, Brazil

Sandro C. Esteves

Medical Director Professor of Urology, University of Campinas (UNICAMP)

Rita Figueira

Laboratory Supervisor

Arnold P. Achermann

Fellow in Male Infertility

Ricardo Miyaoka

Reproductive Urologist Professor of Urology, University of Campinas (UNICAMP)

Fabiola Bento

Quality Manager

Fabiana Y. Nakano

Consultant, Reproductive Endocrinology and Infertility

Fertility Center Hamburg (FCH) Hamburg, Germany

Robert Fischer

Reproductive Endocrinologist

Kimberly Kienast

Head of the IVF and Andrology Laboratoriesy

Wolfgang Schulze

Andrologist

University of North Carolina (UNC) Fertility Male Reproductive Medicine and Surgery Chapel Hill, NC, USA

R. Matthew Coward

Director of Male Reproductive Medicine and Surgery

Vaishnavi Purusothaman

Fellow in Reproductive Endocrinology and Infertility

Steven L. Young

Professor of Obstetrics and Gynecology

Caitlin Boylan

Embryologist

John A. Lee

Fellow in Andrology

Daquan Dock

Andrology Supervisor

Audrey S. Garneau

Fellow in Reproductive Endocrinology and Infertility

Instituto Valenciano de Infertilidad (IVI) Valencia, Spain

Nicolás Garrido

Director of the Andrology Laboratory and Sperm Bank

Educational Format

The virtual preceptorship will feature:

7 Video lectures

that will be released throughout the course period with subtitles in Chinese, Portuguese, Spanish.

6 Scribing Mapping

Of the video lectures that were released throughout the last Virtual World Conference on Luteinizing Hormone in ART: A New Galaxy is Born!

3 live sessions

(practical session in three ‘host’ clinics) will be streamed live and each session will provide the opportunity for more practical in-depth learning.

Chat room

During the three live sessions, users will be able to enter the chat room to discuss and ask interesting topics and debate with colleagues.

Diploma and Certificate

After competition of the activities HCP will receive Certificate and Diploma signed by the Chairs.

library

with a collection of articles related to the program will be provided.

Case study submission

3 live practical sessions in three ‘host’ clinics, has engaged a group of participants that have prepared case studies and became an “Active participant” in the live sessions.

Live Session Videos

Video Lectures

Library Videos

Library Slides

Case Study Androfert
Non-obstructive azoospermia...
Male infertility work-up...
Andrology laboratory...
Contemporary role of testicular..
Medical treatment: what can…
Varicocele: revisiting its role..
Obstructive Azoospermia: ...
Non-Obstructive Azoospermia…

Preliminary Programme

Download PDF

Agenda

Partnership

This program is designed in partnership with the Brazilian Society of Urology (São Paulo Section) and the Portuguese Society of Reproductive Medicine.

CME Provider

Med.E.A – Medical Education Academy

chloe.xilinas@medeaacademy.com

Host Clinics

Funding

Med.E.A Srl educational programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.
These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. Our educational activities are supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, Germany; FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S., Androfert Andrology & Human Reproduction Clinic; MVZ Fertility Center Hamburg GmbH; University of North Carolina at Chapel Hill; Reproductive Medicine Agency (Nova Clinic)

· Sandro C. Esteves ·

Sandro C. Esteves, MD., PhD. is a reproductive urologist who specializes in treating male infertility, particularly its connection with assisted reproductive technology (ART). He is the founder and medical director of ANDROFERT, a fertility center based in Campinas, Brazil, dedicated to male reproductive health. He is also a Collaborating Professor of Urology at the University of Campinas (UNICAMP), Brazil, and an Honorary Professor of Reproductive Medicine at Aarhus University, Denmark.

Dr. Esteves earned his medical degree in 1990 from the Faculty of Medical Sciences at UNICAMP, where he also completed his urology residency. He pursued a research fellowship at the Cleveland Clinic Foundation in the United States, focusing on male infertility. He later obtained a master’s degree in Surgery from UNICAMP and a PhD in Urology from the Federal University of São Paulo (EPM–UNIFESP). With more than 25 years of experience, Dr. Esteves has significantly advanced our understanding of male infertility in both clinical and academic settings. His work has focused on sperm DNA fragmentation, the importance of accurate semen analysis, and the limitations of basic diagnostics. He has underscored the role of varicocele repair and hormonal therapy in improving male fertility, particularly in non-obstructive azoospermia. He is the lead author of the APHRODITE criteria, a novel classification system designed to guide the treatment of men with testicular dysfunction and improve fertility outcomes through personalized hormonal therapy.

Dr. Esteves is a prolific author with over 350 published scientific papers, as well as numerous book chapters, and textbooks. He holds a Hirsch index of 78 and has been cited over 20,ooo times. According to the Science-Wide Author Databases of Standard Citation Indicators (Elsevier/Stanford), he is ranked among the top 1% of global researchers. He is a founding member of the POSEIDON group, which developed new stratification criteria for couples with a low prognosis undergoing ART. In addition to his clinical work and research, Dr. Esteves serves as Associate Editor/Section Editor for several journals, including Human Reproduction, Andrology, Reproductive Biomedicine Online, Frontiers in Endocrinology, and the International Brazilian Journal of Urology. He is also an editorial board member of many journals, including Nature Reviews Urology and International Urology and Nephrology. At ANDROFERT, Dr. Esteves has led initiatives to implement cleanroom technologies and quality management systems (ISO 9001), achieving national recognition for excellence in male fertility care. His team has consistently delivered outstanding results in treating complex cases of male infertility. A frequent speaker at national and international conferences, Dr. Esteves has received numerous research grants and awards. He serves as the head of the Andrology Committee at the Brazilian Society of Human Reproduction and is the Topic Leader of the Male Infertility Group for the WHO Infertility Guidelines.

· Carlo Alviggi ·

Carlo Alviggi earned his MD degree in 1994, from the Faculty of Medicine of the University of Naples “Federico II” in Naples, Italy; he specialized in obstetrics and gynaecology in 1998, and gained a PhD in 2001, from the same university. During his career, he collaborated with: The Imperial College of London, in London, UK; the Laboratory of Immunology of the Italian National Research Council in Naples; and the Autoimmunity and Tolerance Laboratory of the University of California in Los Angeles, CA, USA. This network resulted in various publications, some of which concern new hypotheses on the pathogenesis of pelvic endometriosis. He is now an associate professor in reproductive medicine at the Fertility Unit of the University of Naples “Federico II”. Professor Alviggi’s current research interests are the role of luteinizing hormone (LH) in folliculogenesis; the use of LH-containing drugs in patients undergoing ovarian controlled stimulation for IVF; the pathogenesis of pelvic endometriosis; oncofertility; reproductive endicrinology and the genetics of human reproduction. He has participated in several national and international (phase 2 and 3) multicentric, prospective randomized trials. Professor Alviggi has published extensively and has been invited to lecture at over 200 international meetings dealing with reproductive medicine and gynaecological endocrinology; he is also starter and co-founder of the Poseidon group, an international collaborative network dedicated to low prognosis patients in Assisted Reproductive Technology and vice-President of the “Società Italiana di Fertilità e Sterilità – Medicina della Riproduzione”.

· Robert Fischer ·

Robert Fischer is the founder and Medical Director of the Fertility Center Hamburg (FCH) in Hamburg, Germany. Dr Fischer trained in obstetrics and gynaecology at the University Hospital of Münster, Germany, from 1979 to 1982 and at the Queen’s Medical Centre, University of Nottingham, UK. In 1983, Dr Fischer pioneered the first German outpatient IVF unit in Hamburg and became its Medical Director. The unit moved to a new location in 1998, and its name was changed to the “Fertility Center Hamburg”.

In July 1998, the Fertility Center Hamburg was one of the first centres, both in Germany and worldwide, to introduce quality management, and it was certified according to the ISO 9001 and accredited for IVF laboratories (ISO 17025). Dr Fischer’s main research interests are in the development of stimulation protocols, luteinizing hormone supplementation, and gonadotropin-releasing hormone agonist triggering, as well as further development of quality management systems in IVF centres. He is a founding member of the European Society of Human Reproduction and Embryology (ESHRE); a founding member of the POSEIDON (Patient Oriented Strategies Encompassing IndividualizeD Oocyte Number) group);  Member of the  Scientific Committee of Excellence in Medical Education (EXCEMED- formerly the Serono Symposia International Foundation) and Scientific director of  Med.E.A.( Medical Education Academy)

· Peter Humaidan ·

Professor Peter Humaidan is a specialist in reproductive endocrinology, professor at The Fertility Clinic Skive Regional Hospital, Aarhus University, Denmark and Honorary professor at Odense University, Denmark. During his scientific work he has primarily focused on developing individualized treatment protocols for the infertile patient. His doctoral thesis (DMSc) explored the role of LH during the follicular and luteal phases in controlled ovarian stimulation. His main fields of interest are triggering of ovulation with GnRH agonist, role of LH during the follicular and luteal phases, role of the female genital tract microbiota for reproductive outcomes, OHSS prevention, and role of sperm DNA fragmentation for spontaneous and assisted reproduction. He is the founder of the international society “The Copenhagen GnRHa Triggering Workshop Group” who introduced the GnRHa trigger in modern IVF, changing trigger policies worldwide. He is co-founder of the POSEIDON group which suggested a new stratification of the poor responder patient, and a past board member of the ESHRE SIG Endocrinology Group. Finally, he is also co-founder of the APHRODITE group which suggested a new classification of the infertile male into five sub-groups who might benefit from medical treatment in terms of spermatogenesis. He is in the Elsevier, Stanford global list of 2% top scientists, and he authored and co-authored 270 + articles (H-index 70, Google Scholar) in international peer reviewed journals as well as chapters in textbooks and the Danish guidelines for OHSS prevention. Peter Humaidan has a wide international scientific network and is frequently invited as a speaker at international conferences.

Join our Newsletter!

Stay in the know with our CME updates

Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.